Acumen Pharmaceuticals
ABOS
ABOS
79 hedge funds and large institutions have $73.1M invested in Acumen Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
32% less capital invested
Capital invested by funds: $108M → $73.1M (-$34.6M)
68% less call options, than puts
Call options by funds: $64K | Put options by funds: $201K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
79
Holding in Top 10
–
Calls
$64K
Puts
$201K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$204K | |
| 3 | +$162K | |
| 4 |
Pathstone Holdings
Englewood,
New Jersey
|
+$154K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$137K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$843K | |
| 3 | -$793K | |
| 4 |
Jane Street
New York
|
-$786K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$474K |